Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation

Archives of Dermatology

Volumn 133, Issue 12, 1997, Pages 1530-1533

  Abdel Naser, M Badawy ^a   Hann, Seung Kyung ^a   Bystryn, Jean Claude ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; PSORALEN;

ADULT; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; DRUG BLOOD LEVEL; FEMALE; FIBROBLAST; HUMAN; MALE; MELANOCYTE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PUVA; SKIN PIGMENTATION; SKINFOLD THICKNESS; ULTRAVIOLET A RADIATION;

EID: 0030735456     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.12.1530     Document Type: Article

References (15)

1. Hoenigsmann H, Fitzpatrick TB, Pathak MA, Wolff K. Oral photochemotherapy with psoralens and UVA (PUVA): principles and practice. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in General Medicine. New York, NY: McGraw Hill Book Co; 1993:1743-1744.
2. Parrish JA, Fitzpatrick TB, Shea C, Pathak M. Photochemotherapy of vitiligo: use of orally administered psoralens and a high intensity long-wave ultraviolet system. Arch Dermatol. 1976;112:1531-1534.
3. Friedmann PS, Gilchrest BA. Ultraviolet directly induces pigment production by cultured human melanocytes. J Cell Physiol. 1987;133:88-94.
4. Kao C-H, Yu H-S. Comparison of the effect of 8-methoxypsoralen (8-MOP) plus UVA (PUVA) on human melanocytes in vitiligo vulgaris and in vitro. J Invest Dermatol. 1992;98:734-740.
5. Halaban R, Langdon R, Birchall N, et al. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol. 1988;107:1611-1619.
6. Gordon PR, Mansur CP, Gilchrest BA. Regulation of human melanocyte growth, dendricity and melanization by keratinocyte derived factors. J Invest Dermatol. 1989;92:565-572.
7. Gilchrest BA, Vrabel MA, Flynn E, Szabo G. Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol. 1984;83:370-376.
8. Norris DA, Kissinger MR, Naughton GM, Bystryn J-C. Evidence for immunologie mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. J Invest Dermatol. 1988;90:783-789.
9. Krasagakis K, Garbe C, Kruger-Krasagakes S, Orfanos CE. 12-0-tetradecanoylphorbol-13-acetate not only modulates proliferation rates but also alters antigenexpression and LAK cell susceptibility of normal human melanocytes in vitro. J Invest Dermatol. 1993;100:653-659.
10. Cordell JL, Fallini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984; 32:219-229.
11. Puglisi CV, de Silva JAF, Meyer JC. Determination of 8-methoxypsoralen, a photosensitive compound, in blood by high pressure liquid chromatography. Anal Lett 1977;10:39-50.
12. Stierner U, Rosdahl I. Augustsson A, Kagedal B. UVB irradiation induces melanocyte increase in both exposed and shielded skin. J Invest Dermatol. 1989;92:561-564.
13. Anletta M, Gange RW, Tan OT, Matzinger EA. The differential effect of cutaneous blood flow upon the induction of UVA and UVB pigment responses in human skin. J Invest Dermatol. 1984;82:420. Abstract.
14. Tegner E, Roosman H, Rosengren E. 5-S-Cysteinyldopa and pigment response to UVA light. Acta Derm Venereol (Stockh). 1983;63:21-25.
15. Epstein JH, Fukuyama K, Fye K. Effects of ultraviolet radiation on the mitotic cycle and DNA. RNA and protein synthesis in mammalian epidermis in vivo. Photochem Photobiol. 1970;12:57-65.